Literature DB >> 16227627

The proto-oncoprotein SYT interacts with SYT-interacting protein/co-activator activator (SIP/CoAA), a human nuclear receptor co-activator with similarity to EWS and TLS/FUS family of proteins.

Michela Perani1, Per Antonson, Rifat Hamoudi, Catherine J E Ingram, Colin S Cooper, Michelle D Garrett, Graham H Goodwin.   

Abstract

The proto-oncoprotein SYT is involved in the unique translocation t(X;18) found in synovial sarcoma SYT-SSX fusions. SYT has a conserved N-terminal domain (SNH domain) that interacts with the human paralog of Drosophila Brahma (hBRM) and Brahma-related gene 1 (BRG1) chromatin remodeling proteins and a C-terminal transactivating sequence rich in glutamine, proline, glycine, and tyrosine (QPGY domain). Here we reported the isolation of the ribonucleoprotein SYT-interacting protein/co-activator activator (SIP/CoAA), which specifically binds the QPGY domain of SYT and also the SYT-SSX2 translocation fusion. SIP/CoAA is a general nuclear co-activator and an RNA splicing modulator that contains two RNA recognition motifs and multiple hexapeptide repeats. We showed that the region consisting of the hexapeptide motif (YQ domain) is similar to the hexapeptide repeat domain found in EWS and in TLS/FUS family proteins. The YQ domain also resembles the QPGY region of SYT itself and like all these other domains acts as a transcriptional activator in reporter assays. Most interestingly, the last 84 amino acids adjacent to YQ down-modulate by 25-fold the YQ transactivation of the reporter gene, and both domains are important for SIP/CoAA binding to SYT. In addition, SYT acts together with SIP/CoAA in stimulating estrogen and glucocorticoid receptor-dependent transcriptional activation. Activation is hormone-dependent and requires functional hBRM and/or BRG1. The stimulation is strongly reduced if the N-terminal region of hBRM/BRG1 (amino acids 1-211) is deleted. This region encompasses the SNF11 binding domain (amino acids 156-211), which interacts specifically with SYT in vivo and in vitro.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16227627     DOI: 10.1074/jbc.M502963200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  20 in total

1.  SYT-SSX1 (synovial sarcoma translocated) regulates PIASy ligase activity to cause overexpression of NCOA3 protein.

Authors:  Yin Sun; Juanita Perera; Brian P Rubin; Jiaoti Huang
Journal:  J Biol Chem       Date:  2011-03-24       Impact factor: 5.157

Review 2.  Synovial sarcoma: recent discoveries as a roadmap to new avenues for therapy.

Authors:  Torsten O Nielsen; Neal M Poulin; Marc Ladanyi
Journal:  Cancer Discov       Date:  2015-01-22       Impact factor: 39.397

3.  Dual roles for coactivator activator and its counterbalancing isoform coactivator modulator in human kidney cell tumorigenesis.

Authors:  Yun Kyoung Kang; Rachel Schiff; Lan Ko; Tao Wang; Sophia Y Tsai; Ming-Jer Tsai; Bert W O'Malley
Journal:  Cancer Res       Date:  2008-10-01       Impact factor: 12.701

4.  The Arabidopsis GRF-INTERACTING FACTOR gene family performs an overlapping function in determining organ size as well as multiple developmental properties.

Authors:  Byung Ha Lee; Jae-Heung Ko; Sangman Lee; Yi Lee; Jae-Hong Pak; Jeong Hoe Kim
Journal:  Plant Physiol       Date:  2009-07-31       Impact factor: 8.340

5.  Identification and analysis of CXCR4-positive synovial sarcoma-initiating cells.

Authors:  T Kimura; L Wang; K Tabu; M Tsuda; M Tanino; A Maekawa; H Nishihara; H Hiraga; T Taga; Y Oda; S Tanaka
Journal:  Oncogene       Date:  2015-12-07       Impact factor: 9.867

6.  The proto-oncoprotein SYT (SS18) controls ATP release and regulates cyst formation by polarized MDCK cells.

Authors:  Manesh Chittezhath; Andrea L Frump; Jerome Jourquin; Nichole Lobdell; Josiane E Eid
Journal:  Exp Cell Res       Date:  2008-09-20       Impact factor: 3.905

7.  The extracellular domain of the growth hormone receptor interacts with coactivator activator to promote cell proliferation.

Authors:  Becky L Conway-Campbell; Andrew J Brooks; Philip J Robinson; Michela Perani; Michael J Waters
Journal:  Mol Endocrinol       Date:  2008-07-17

8.  Co-activator activator (CoAA) prevents the transcriptional activity of Runt domain transcription factors.

Authors:  Xiaodong Li; Luke H Hoeppner; Eric D Jensen; Rajaram Gopalakrishnan; Jennifer J Westendorf
Journal:  J Cell Biochem       Date:  2009-10-01       Impact factor: 4.429

9.  SS18 together with animal-specific factors defines human BAF-type SWI/SNF complexes.

Authors:  Evelien Middeljans; Xi Wan; Pascal W Jansen; Vikram Sharma; Hendrik G Stunnenberg; Colin Logie
Journal:  PLoS One       Date:  2012-03-19       Impact factor: 3.240

10.  Epigenetic features of human mesenchymal stem cells determine their permissiveness for induction of relevant transcriptional changes by SYT-SSX1.

Authors:  Luisa Cironi; Paolo Provero; Nicola Riggi; Michalina Janiszewska; Domizio Suva; Mario-Luca Suva; Vincent Kindler; Ivan Stamenkovic
Journal:  PLoS One       Date:  2009-11-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.